Ajanta Pharmaceuticals Profit & Loss Annual

BSE: 532331 | NSE: AJANTPHARM | ISIN: INE031B01049 | Sector: Biotechnology & Drugs

3,001.80 +41.50 (1.40%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	4,208.71	3,742.64	3,340.99	2,889.69
Total Revenue	4,208.71	3,742.64	3,340.99	2,889.69
Costof Revenue Total	1,066.57	1,116.73	886.72	682.39
Gross Profit	3,142.14	2,625.91	2,454.27	2,207.30
Selling/ General/ Admin Expenses Total	900.34	1,774.38	1,481.72	1,171.06
Depreciation/ Amortization	135.40	130.31	124.82	115.60
Other Operating Expenses Total	1,069.86	40.13	35.39	27.91
Total Operating Expense	3,172.17	3,062.04	2,533.12	2,005.01
Operating Income	1,036.54	680.60	807.87	884.68
Interest Inc( Exp) Net- Non- Op Total	-72.10	646.90	901.90	121.10
Other Net	84.60	6.15	15.29	5.60
Net Income Before Taxes	1,113.93	745.25	909.48	900.18
Provisionfor Income Taxes	297.76	157.27	196.79	246.31
Net Income After Taxes	816.17	587.98	712.69	653.87
Net Income Before Extra Items	816.17	587.98	712.69	653.87
Net Income	816.17	587.98	712.69	653.87
Income Availableto Com Excl Extra Ord	816.17	587.98	712.68	653.87
Income Availableto Com Incl Extra Ord	816.17	587.98	712.68	653.87
Diluted Net Income	816.17	587.98	712.68	653.87
Diluted Weighted Average Shares	12.60	12.81	12.97	13.06
Diluted EPS Excluding Extra Ord Items	64.77	45.89	54.96	50.06
DPS- Common Stock Primary Issue	10.00	7.00	6.33	6.33
Diluted Normalized EPS	64.77	46.27	55.44	50.60
Interest Exp( Inc) Net- Operating Total	-	4.90	4.90	4.90
Gain( Loss)on Saleof Assets	-	-61.90	-38.70	-22.10
Unusual Expense( Income)	-	-	3.98	7.56
Total Adjustmentsto Net Income	-	-	-0.10	-